News | December 14, 2021
Lupin’s Goa plant receives EIR from US FDA
FDA changes inspection classification of the facility to Voluntary Action Indicated
FDA changes inspection classification of the facility to Voluntary Action Indicated
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
The union health ministry notifies the protocol and this move will also help in organ donation
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Subscribe To Our Newsletter & Stay Updated
